FYB2

Chr 1

FYN binding protein 2

Also known as: ARAP, C1orf168

This protein functions as an adapter in T-cell receptor signaling and integrin-mediated T-cell adhesion, playing a critical role in T-cell activation. Mutations cause autosomal recessive combined immunodeficiency with autoimmunity and allergies, typically presenting in early childhood with recurrent infections and immune dysregulation. The gene shows low constraint to loss-of-function variants, consistent with its recessive inheritance pattern.

OMIMResearchSummary from RefSeq, UniProt
MultiplemechanismLOEUF 1.70
Clinical SummaryFYB2
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
9 unique Pathogenic / Likely Pathogenic· 13 VUS of 49 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.70LOEUF
pLI 0.000
Z-score -2.09
OE 1.36 (1.091.70)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
-0.33Z-score
OE missense 1.05 (0.961.14)
379 obs / 361.4 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios
LoF OE1.36 (1.091.70)
00.351.4
Missense OE1.05 (0.961.14)
00.61.4
Synonymous OE0.98
01.21.6
LoF obs/exp: 54 / 39.8Missense obs/exp: 379 / 361.4Syn Z: 0.19
DN
0.74top 25%
GOF
0.7028th %ile
LOF
0.3357th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to dominant-negative as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

49 submitted variants in ClinVar

Classification Summary

Pathogenic7
Likely Pathogenic2
VUS13
Likely Benign1
7
Pathogenic
2
Likely Pathogenic
13
VUS
1
Likely Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
7
0
7
Likely Pathogenic
0
0
2
0
2
VUS
0
6
7
0
13
Likely Benign
0
0
0
1
1
Benign
0
0
0
0
0
Total0616123

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

FYB2 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →
Key Publications
Landmark & review papers · by relevance
PubMed
Top 3 results · since 2015Search PubMed ↗
Recent Gene-Specific Literature
Gene in title · MEDLINE · newest first
Europe PMC

No open access results found